Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3488323016 | Product containing afatinib (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3713014013 | Afatinib-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1681000188119 | afatinib | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| 50014831000188118 | médicament contenant afatinib | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing afatinib (medicinal product) | Is a | Product containing protein-tyrosine kinase inhibitor (product) | true | Inferred relationship | Some | ||
| Product containing afatinib (medicinal product) | Has active ingredient | Afatinib (substance) | true | Inferred relationship | Some | 1 | |
| Product containing afatinib (medicinal product) | Is a | Medicinal product categorized by structure | false | Inferred relationship | Some | ||
| Product containing afatinib (medicinal product) | Is a | Product containing enzyme inhibitor (product) | false | Inferred relationship | Some | ||
| Product containing afatinib (medicinal product) | Is a | Product containing quinazoline (product) | true | Inferred relationship | Some | ||
| Product containing afatinib (medicinal product) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing afatinib (medicinal product) | Is a | Antineoplastic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely afatinib dimaleate 20 milligram/1 each conventional release oral tablet | Is a | False | Product containing afatinib (medicinal product) | Inferred relationship | Some | |
| Product containing precisely afatinib dimaleate 30 milligram/1 each conventional release oral tablet | Is a | False | Product containing afatinib (medicinal product) | Inferred relationship | Some | |
| Product containing precisely afatinib dimaleate 40 milligram/1 each conventional release oral tablet | Is a | False | Product containing afatinib (medicinal product) | Inferred relationship | Some | |
| Afatinib-containing product in oral dose form | Is a | True | Product containing afatinib (medicinal product) | Inferred relationship | Some | |
| Product containing only afatinib (medicinal product) | Is a | True | Product containing afatinib (medicinal product) | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR